Explore Selank Amidate dosage trends, reconstitution volumes, and vial size patterns from anonymized WPA peptide calculator sessions.
Selank Amidate is the C-terminally amidated form of Selank, a synthetic heptapeptide based on the immunomodulatory fragment of tuftsin, studied for its proposed anxiolytic and nootropic effects. The amidation is intended to improve metabolic stability versus the standard acetate form. This data shows the dose amounts, vial sizes, and bacteriostatic water volumes researchers most commonly select when reconstituting Selank Amidate.
Selank Amidate is the C-terminal amide version of Selank, a synthetic anxiolytic heptapeptide studied for anxiety and immune-modulation research. It ships as a lyophilized powder, and the one thing worth verifying over plain Selank is that the C-terminal amide is actually present.
Mechanism is presumed equivalent to free-acid Selank: modulation of GABA-A receptor subunit expression rather than direct benzodiazepine-site binding, with secondary serotonergic and enkephalinase-inhibition activity inherited from the tuftsin parent. No published study has directly compared receptor pharmacology of the amidate against the free-acid form.
No clinical trial or peer-reviewed pre-clinical study has been published on the amidate variant specifically; the Russian clinical literature underlying the Selank registration used the free-acid form. The amidate variant exists primarily as a research-peptide vendor offering marketed as "more stable" than free-acid Selank, on the general medicinal-chemistry principle that C-terminal amidation slows carboxypeptidase cleavage.
Selank Amidate has a reported half-life of ~30 min, and the dose intervals researchers model most often fall around twice daily (intranasal). Like standard Selank, the amidated form clears from plasma within an hour and works as discrete pulses rather than building to a steady level. Frequency and timing matter more than total dose. It is catalogued under Memory Peptides on WPA.
2 Selank Amidate reconstitution calculations have been logged by the WPA community. The most common dose entered is 300mcg (1 calculations). The median dose across all sessions is 500mcg. The most common bacteriostatic water volume is 3mL. The most popular vial size is 30mg (2 sessions). The most common dosing frequency is daily (7x/week) (1 logged protocols).
These figures come from anonymized WPA peptide calculator sessions.
All figures shown are aggregated from anonymized calculator inputs and are provided strictly for independent laboratory research and educational purposes. They are community usage statistics — not dosing recommendations, and not medical advice.